JASON KIMATA to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications JASON KIMATA has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.297
-
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy. J Antimicrob Chemother. 2024 02 01; 79(2):370-374.
Score: 0.225
-
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007 Nov; 81(22):12145-55.
Score: 0.072